Chiesi Farmaceutici Overview

  • Year Founded
  • 1935

Year Founded

  • Status
  • Private

  • Employees
  • 7,900

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $758M

Chiesi Farmaceutici General Information

Description

Manufacturer and Provider of biopharmaceutical research and therapeutic solutions headquartered in Parma, Italy. The company develops and produces pharmaceutical products specializing in respiratory health, rare diseases, and specialty care, operating multiple global production plants that manufacture life-saving medicines for neonatology, transplantation, and chronic respiratory conditions.

Contact Information

Website
www.chiesi.com
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Corporate Office
  • Via Paradigna 131/A
  • 43122 Parma
  • Italy
+39 0521
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • Via Paradigna 131/A
  • 43122 Parma
  • Italy
+39 0521

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chiesi Farmaceutici Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Debt - General 12-Apr-2023 $758M Completed Generating Revenue
To view Chiesi Farmaceutici’s complete valuation and funding history, request access »

Chiesi Farmaceutici Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and Provider of biopharmaceutical research and therapeutic solutions headquartered in Parma, Italy. The com
Pharmaceuticals
Parma, Italy
7,900 As of 2026

Toluca, Mexico
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Chiesi Farmaceutici Competitors (32)

One of Chiesi Farmaceutici’s 32 competitors is Landsteiner Scientific, a Formerly PE-Backed company based in Toluca, Mexico.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Landsteiner Scientific Formerly PE-Backed Toluca, Mexico
Novartis Corporation Basel, Switzerland
Johnson&Johnson Innovative Medicine Venture Capital-Backed Raritan, NJ
Recordati Private Equity-Backed Milan, Italy
Astellas Pharma Corporation Tokyo, Japan
You’re viewing 5 of 32 competitors. Get the full list »

Chiesi Farmaceutici Patents

Chiesi Farmaceutici Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026201946-A1 Dry powder formulations for inhalation in form of soft pellets Pending 28-Mar-2025
WO-2026162317-A1 Treatment of progressive chronic interstitial lung disease with an anti-tg2 antibody Pending 28-Jan-2025
WO-2026120023-A1 Azaspiroheptane derivatives as ddr inhibitors Pending 04-Dec-2024
WO-2026120024-A1 Azaspiroheptane derivatives as ddr inhibitors Pending 04-Dec-2024
WO-2026027399-A1 Device for testing medicament inhalers Pending 29-Jul-2024 G01M99/00
To view Chiesi Farmaceutici’s complete patent history, request access »

Chiesi Farmaceutici Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chiesi Farmaceutici Investments & Acquisitions (23)

Chiesi Farmaceutici’s most recent deal was a Merger/Acquisition with KalVista Pharmaceuticals for . The deal was made on 11-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
KalVista Pharmaceuticals 11-Jun-2026 Merger/Acquisition Drug Discovery
Chiesi Farmaceutici (Nerviano Manufacturing Plant in Nerviano, Italy) 26-Mar-2025 Corporate Asset Purchase Buildings and Property
Santhera Pharmaceuticals (Idebenone Business) 28-Jul-2023 Merger/Acquisition Biotechnology
Amryt Pharma 12-Apr-2023 Merger/Acquisition Drug Discovery
Allinaire Therapeutic ( Worldwide Rights To a Portfolio of Therapeutic Monoclonal Antibodies) 02-May-2022 Corporate Asset Purchase Drug Discovery
You’re viewing 5 of 23 investments and acquisitions. Get the full list »

Chiesi Farmaceutici Affiliates

Subsidiaries (10)

Name Industry Location Year Founded
Unikeris Manchester, United Kingdom 2020
Amryt Pharma London, United Kingdom 2015
Chiesi Ventures Boston, MA 2014
Atopix Oxon, United Kingdom 2012
KalVista Pharmaceuticals Framingham, MA 2011
You’re viewing 5 of 10 affiliates. Get the full list.  »

Chiesi Farmaceutici FAQs

  • When was Chiesi Farmaceutici founded?

    Chiesi Farmaceutici was founded in 1935.

  • Where is Chiesi Farmaceutici headquartered?

    Chiesi Farmaceutici is headquartered in Parma, Italy.

  • What is the size of Chiesi Farmaceutici?

    Chiesi Farmaceutici has 7,900 total employees.

  • What industry is Chiesi Farmaceutici in?

    Chiesi Farmaceutici’s primary industry is Pharmaceuticals.

  • Is Chiesi Farmaceutici a private or public company?

    Chiesi Farmaceutici is a Private company.

  • What is Chiesi Farmaceutici’s current revenue?

    The current revenue for Chiesi Farmaceutici is .

  • How much funding has Chiesi Farmaceutici raised over time?

    Chiesi Farmaceutici has raised $758M.

  • Who are Chiesi Farmaceutici’s competitors?

    Landsteiner Scientific, Novartis, Johnson&Johnson Innovative Medicine, Recordati, and Astellas Pharma are some of the 32 competitors of Chiesi Farmaceutici.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process